ICA Group Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,427
Closed -$97.7K 848
2024
Q1
$97.7K Sell
1,427
-101
-7% -$6.49K 0.02% 403
2023
Q4
$88.3K Buy
+1,528
New +$81.6K 0.02% 380
2023
Q3
Sell
-1,580
Closed -$85.5K 350
2023
Q2
$85.5K Buy
1,580
+1,339
+556% +$69.9K 0.02% 368
2023
Q1
$12.1K Hold
241
﹤0.01% 772
2022
Q4
$11.2K Buy
+241
New +$10.4K ﹤0.01% 805

Other funds holding BSX

ICA Group Wealth Management's BSX Position: Q2 2024 in Review

ICA Group Wealth Management sold out of Boston Scientific (BSX) in Q2 2024, closing a stake of 1,427 shares — an estimated $97.7K sold.

ICA Group Wealth Management first reported a position in BSX in Q4 2022 and held it in 5 quarters. The position peaked at $97.7K in Q1 2024. 1,317 funds tracked by Wall St. Rank hold BSX as of Q2 2024.

  • ICA Group Wealth Management reported no remaining Boston Scientific position as of Q2 2024 after selling out during the quarter.
  • ICA Group Wealth Management sold 1,427 Boston Scientific shares in Q2 2024, an estimated $97.7K.
  • ICA Group Wealth Management first reported a position in Boston Scientific in Q4 2022 and held it in 5 quarters.
  • ICA Group Wealth Management's Boston Scientific position peaked at $97.7K in Q1 2024.
  • 1,317 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.